GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » Aceso Life Science Group Ltd (HKSE:00474) » Definitions » Operating Cash Flow per Share

Aceso Life Science Group (HKSE:00474) Operating Cash Flow per Share : HK$0.01 (TTM As of Sep. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Aceso Life Science Group Operating Cash Flow per Share?

Aceso Life Science Group's operating cash flow per share for the six months ended in Sep. 2023 was HK$0.00. Aceso Life Science Group's operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2023 was HK$0.01.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Aceso Life Science Group was -71.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Aceso Life Science Group's Operating Cash Flow per Share or its related term are showing as below:

During the past 13 years, Aceso Life Science Group's highest 3-Year average Operating Cash Flow per Share Growth Rate was 67.50% per year. The lowest was -48.50% per year. And the median was 4.60% per year.

HKSE:00474's 3-Year OCF Growth Rate is not ranked *
in the Conglomerates industry.
Industry Median: 5.8
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Aceso Life Science Group Operating Cash Flow per Share Historical Data

The historical data trend for Aceso Life Science Group's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aceso Life Science Group Operating Cash Flow per Share Chart

Aceso Life Science Group Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.02 -0.06 0.03 0.04 0.03

Aceso Life Science Group Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.02 0.01 -

Competitive Comparison of Aceso Life Science Group's Operating Cash Flow per Share

For the Conglomerates subindustry, Aceso Life Science Group's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aceso Life Science Group's Price-to-Operating-Cash-Flow Distribution in the Conglomerates Industry

For the Conglomerates industry and Industrials sector, Aceso Life Science Group's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Aceso Life Science Group's Price-to-Operating-Cash-Flow falls into.



Aceso Life Science Group Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Aceso Life Science Group's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (A: Mar. 2023 )=Cash Flow from Operations (A: Mar. 2023 )/Shares Outstanding (Diluted Average) (A: Mar. 2023 )
=222/7318.000
=0.03

Aceso Life Science Group's Operating Cash Flow per Share for the quarter that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (Q: Sep. 2023 )=Cash Flow from Operations (Q: Sep. 2023 )/Shares Outstanding (Diluted Average) (Q: Sep. 2023 )
=31/7274.000
=0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aceso Life Science Group Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Aceso Life Science Group's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Aceso Life Science Group (HKSE:00474) Business Description

Traded in Other Exchanges
N/A
Address
6 - 8 Harbour Road, Rooms 2501 - 2509, 25th Floor, Shui On Centre, Wanchai, Hong Kong, HKG
Aceso Life Science Group Ltd is an investment holding company. The group's operating segments include Money lending; Rental and sale of construction machinery and spare parts business; Provision of repair and maintenance and transportation service business; Provision of asset management, securities brokerage, commodities, futures and other financial service business; Property leasing business; and Property development business. It derives key revenue from the rental and sale of construction machinery and spare part. Geographically, the group has a business presence in Hong Kong, the UK, the PRC, Macau and Cambodia.
Executives
Li Shao Yu 2101 Beneficial owner
Asia Link Capital Investment Holdings Limited 2201 Interest of corporation controlled by you
Haitong International Holdings Limited
Huang Tao 2201 Interest of corporation controlled by you
Huang Shiying 2201 Interest of corporation controlled by you
Century Golden Resources Investment Co., Ltd 2101 Beneficial owner
Haitong International Securities Group (singapore) Pte. Ltd.
Haitong International Financial Products (singapore) Pte. Ltd.
Haitong Securities Co., Ltd.
Haitong International Securities Group Limited
Atlantis Capital Group Holdings Limited
Co-high Investment Management Limited
Liu Yang
Dong Zimeng
East Jumbo Development Limited 2501 Other

Aceso Life Science Group (HKSE:00474) Headlines

No Headlines